The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Transforming tuberculosis diagnosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A simple, non-sputum sample combined with an affordable, multi-disease point-of-care molecular technology deployed in decentralized settings would reach a much larger population, close the case detection gap, and curb TB transmission at the population level.
““A simple, non-sputum sample,” say Pai et al,53 “combined with an affordable, multi-disease POC molecular technology, deployed in decentralized settings would reach a much larger population, close the case detection gap, and curb TB transmission at the population level.””
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [53]
Diagnosis is the weakest aspect of TB care and control, and without diagnosis the disease cannot be treated.
“Diagnosis, say Pai and colleagues, is “the weakest aspect of TB care and control”—without diagnosis, the disease cannot be treated.53”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [53]
Prior to the COVID-19 pandemic, around 2.9 million people annually had tuberculosis without being diagnosed, and the annual diagnostic gap grew to 4.2 million during the pandemic.
“Prior to the COVID-19 pandemic, around 2.9 million people annually had tuberculosis without being diagnosed, and the annual diagnostic gap grew to 4.2 million during the pandemic.”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal
Kendall, E. A., Shrestha, S., & Dowdy, D. W. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2394pp · Cited by 185
Flagged first, then by citations
Research works printed but not linked: 14
- Global Tuberculosis Report 2022 (World Health Organization, 27 January 2023); https://go.nature.com/3FW2RVs
- Subbaraman, R. et al. PLoS Med. 16, e1002754 (2019). · DOI
- Pai, M., Kasaeva, T. & Swaminathan, S. N. Eng. J. Med. 386, 1490–1493 (2022). · DOI
- McKenna, L. et al. Nat. Med. 29, 16–17 (2023). · DOI
- Hannay, E. & Pai, M. EClinicalMedicine 57, 101867 (2023). · DOI
- Thompson, R. R. et al. Lancet Glob. Health 11, e278–e286 (2023). · DOI
- WHO Standard: Universal Access to Rapid Tuberculosis Diagnostics (World Health Organization, 2023); https://go.nature.com/40kSfqx
- Daniels, B., Kwan, A., Pai, M. & Das, J. J. Clin. Tuberc. Other Mycobact. Dis. 16, 100109 (2019). · DOI
- Fleming, K. A. et al. Lancet 398, 1997–2050 (2021). · DOI
- Girdwood, S. et al. PLoS Glob. Public Health 3, e0001179 (2023). · DOI
- MacLean, E.L.-H. et al. Lancet Microbe https://doi.org/10.1016/S2666-5247(23)00042-3 (2023). · DOI
- Diagnostic Network Optimization: A Network Analytics Approach to Design Patient-centred and Cost-efficient Diagnostic Systems (Foundation for Innovative New Diagnostics, 20 February 2023); https://go.nature.com/3KguYS4
- Nathavitharana, R. R., Garcia-Basteiro, A. L., Ruhwald, M., Cobelens, F. & Theron, G. EBioMedicine 78, 103939 (2022). · DOI
- WHO Consolidated Guidelines on Tuberculosis: Module 2: Screening: Systematic Screening for Tuberculosis Disease (World Health Organization, 20 February 2023); https://go.nature.com/40n9I2w
Cited by
Sorted by citations
Global health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
Diagnosing and Treating Extrapulmonary Tuberculosis in India: Challenges and Solutions
Nischal, N., Nath, R., Rathi, V., & Ish, P. (2024) · Preventive Medicine: Research & Reviews · doi:10.4103/pmrr.pmrr_40_23 · Cited by 10
Metadata
- Authors
- Pai, M., Dewan, P. K., & Swaminathan, S.
- Affiliations
- McGill University (CA)
- Gates Foundation (US)
- M S Swaminathan Research Foundation (IN)
- Corresponding author
- Pai, Madhukar
- Venue
- Nature Microbiology
- Published
- 2023-05-01
- Volume
- 8
- Issue
- 5
- Pages
- 756-759
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W4367609689
- Cited by
- 126
- References
- 1
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 41 · 2023: 7
- FWCI
- 26.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- McGill University
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, drug-resistant tuberculosis, tuberculosis screening, continuum of care, low- and middle-income countries, early detection, short-course treatment, tuberculosis mortality
- MeSH terms
- Humans, Mycobacterium tuberculosis, Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
